Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep844 | Clinical case reports - Pituitary/Adrenal | ECE2017

Case of TSH secreating pituitary adenoma (TSHOMA) where course was modified by coexistant autoimmune hypothyroidism

Joshi Ameya , Ghagre Rajesh , Varthakavi Premlata , Dalwadi Pradeep , Bhagwat Nikhil

Introduction: TSHOMAs are rare pituitary tumors with prevalence of 1–2 cases per million. We present a case of of TSHoma where the course was complicated by the coexistence of autoimmune hypothyroidism.Case: 41 year old male presented with fatigue, lethargy and palpitations. On screening was found to have raised t3 – 216.30 ng/dl (N-70-204 ng/dl), t4 – 12.10 μg/dl(N-4.2-11.6 μg/dl) and TSH – 27.55 uIU/ml (0.2–5.7 uIU/ml...

ea0073aep264 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Treatment recommendations for dapagliflozin across a cardio-renal and viscero metabolic (crv-m) continuum: an expert consensus delphi study

Das Ashok , Awasthi Rajeev , Sahay Manisha , Sahoo Abhay , Hazra Prakash , Kapoor Nitin , Tiwaskar Mangesh , Bhandarkar Prashant , Sahay Rakesh , Bhattacharya Saptarshi , Saboo Banshi , Pandit Kaushik , Kishor Kamal , Marwah Tiven , Agrawal Navneet , Sharma Kamal , Khanna Umesh , Bantwal Ganapathi , Joshi Ameya , Kerkar Prafulla , Kalra Sanjay

IntroductionDapagliflozin is sub-optimally utilised in the real world. There is a lack of a comprehensive collaborative guidance for a practical approach to manage patients with cardiometabolic, renometabolic and viscerometabolic disorders. Patients across the CRV-M continuum includes patients with varied clinical profiles.MethodsTwo round Delphi study was conducted using a virtual online-digital connect appr...